May 12, 2021, 1:17 PM – Updated on May 13, 2021, 12:26 AM
Word Count: 1395
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 14 to 0, with one recusal, on Wednesday to support the two-dose vaccine’s emergency authorization after it was cleared by the Food and Drug Administration on Monday. CDC Director Rochelle Walensky adopted the recommendation after the vote, according to a statement from the agency.
The vaccine could be deployed to teens as soon as Thursday in a move that’s long been anticipated as paving the way for the mass vaccination of middle and high-school students before the next school year begins.
CDC advisers back use of Pfizer-BioNTech vaccine in adolescents
Angelica LaVito and Riley Griffin
Bloomberg
View Comments
A group of medical experts said children ages 12 to 15 years old can safely take the Covid-19 vaccine made by Pfizer Inc. and BioNTech SE, opening an important new phase of the U.S. immunization effort.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 14 to 0, with one recusal, on Wednesday to support the two-dose vaccine’s emergency authorization after it was cleared by the Food and Drug Administration on Monday. CDC Director Rochelle Walensky must now sign off on the recommendation before it becomes final.
May 12, 2021, 1:17 PM – Updated on May 12, 2021, 9:29 PM
Word Count: 1275
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 14 to 0, with one recusal, on Wednesday to support the two-dose vaccine’s emergency authorization after it was cleared by the Food and Drug Administration on Monday. CDC Director Rochelle Walensky must now sign off on the recommendation before it becomes final.
The vaccine could be deployed to teens as soon as Thursday in a move that’s long been anticipated as paving the way for the mass vaccination of middle and high-school students before the next school year begins.
WASHINGTON — Pfizer Inc. and BioNTech SE’s COVID-19 vaccine was cleared for use in children ages 12 to 15 in the U.S., paving the way for the mass vaccination of
The Food and Drug Administration on Monday cleared Pfizer-BioNTech’s coronavirus vaccine for adolescents 12 to 15 years old, enabling millions of more Americans to get the two-shot regimen.